The somatostatin receptor-targeted radiotherapeutic [90Y-DOTA-DPhe1,Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours

European Journal of Nuclear Medicine

Volumn 25, Issue 7, 1998, Pages 668-674

  Stolz, Barbara ^a   Weckbecker, Gisbert ^a   Smith Jones, Peter M ^a,b   Albert, Rainer ^a   Raulf, Friedrich ^a   Bruns, Christian ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Octreotide; Receptor targeted radionuclide therapy; Somatostatin; Yttrium 90

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE N,N,N,N,TETRAACETIC ACID OCTREOTIDE[DEXTRO PHENYLALANINE 1 TYROSINE 3]; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; YTTRIUM 90;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; EXPERIMENTAL NEOPLASM; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PANCREAS TUMOR; RAT;

ANIMALS; HUMANS; OCTREOTIDE; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; RADIOPHARMACEUTICALS; RATS; RATS, INBRED LEW; RECEPTORS, SOMATOSTATIN; TISSUE DISTRIBUTION; YTTRIUM RADIOISOTOPES;

EID: 0031843687     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050268     Document Type: Article

References (29)

1. Reubi JC, Laissue J, Krenning E, Lamberts SW. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Mol Biol 1992; 43: 27-35.
2. Van Hagen PM, Krenning EP, Reubi JC, Mulder AH, Bakker WH, Oei HY, Lowenberg B, Lamberts SW. Somatostatin analogue scintigraphy of malignant lymphomas. Br J Haematol 1993; 83: 75-79.
3. 111InDTPA octreotide scintigraphy. Eur J Cancer 1995; 31A: 194-198.
4. Van Eijck CH, Slooter GD, Hofland LJ, Kort W, Jeekel J, Lamberts SW, Marquet RL. Somatostatin receptor-dependent growth inhibition of liver metastases by octreotide. Br J Surg 1994; 81: 1333-1337.
5. Reubi JC, Schaer JC, Waser B, Mengod G. Expression and localization of somatostatin receptor SSTR1, SSTR2. and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 1994; 54: 3455-3459.
6. 3-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716-731.
7. Stolz B, Smith-Jones P, Albert R, Tolcsvai L, Briner U, Ruser G, Mäcke H, Weckbecker G, Bruns C. Somatostatin analogues for somatostatin-receptor mediated radiotherapy of cancer. Digestion 1996; 57 Suppl 1: 17-21.
8. Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D, Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 1979; 16: 251-270.
9. Smith-Jones PM, Stolz B, Albert R, Ruser G, Briner U, Mäcke HR, Bruns C. Biodistribution and renal handling of various chelate/somatostatin conjugates with potentially kidney specific metabolizable linking groups. Nucl Med Biol 1997; 24: 761-769.
10. 3]-octreotide (SMT487): two chelators for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man. Bioorg Med Chem Lett 1998: in press.
11. 3-octreotide in tumor bearing rodents. J Nucl Med 1997; 38 (5 Suppl): 19P.
12. 3]octreotide, a promising somatostatin analogue for radionuclide therapy. Eur J Nucl Med 1997; 24: 368-371.
13. Hajri A, Bruns C, Marbach P, Aprahamian M, Longnecker DS, Damgé C. Inhibition of the growth of transplanted rat pancreatic acinar carcinoma with octreotide. Eur J Cancer 1991; 27: 1247-1252.
14. Reubi JC. New specific radioligand for one subpopulation of brain somatostatin receptors. Life Sci 1985; 36: 1829-1836.
15. Bruns C, Dietl MM, Palacios JM, Pless J. Identification and characterization of somatostatin receptors in neonatal rat long bones. Biochem J 1990; 65: 39-44.
16. Srikant CB, Patel YC. Somatostatin receptors: identification and characterization in rat brain membranes. Proc Natl Acad Sci USA 1981; 78: 3930-3934.
17. Scatchard G. The attraction of proteins for small molecules and ions. Ann N Y Acad Sci 1949; 51: 660-672.
18. Schloos J, Raulf F, Hoyer D, Bruns C. Identification and pharmacological characterization of somatostatin receptors in rat lung. Br J Pharmacol 1997; 121: 963-971.
19. Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schule R. Cloning and characterization of a fourth human somatostatin receptor. Proc Natl Acad Sci USA 1993; 90: 4196-4200.
20. Hnatowich DJ, Virzi F, Doherty PW. DTPA-coupled antibodies labeled with yttrium-90. J Nucl Med 1985; 26: 503-509.
21. Bruns C, Weckbecker G, Raulf F, Lübbert H, Hoyer D. Characterization of somatostatin receptor subtypes. Ciba Found Symp 1995; 190: 89-101.
22. 3]octreotide. Eur J Nucl Med 1993; 20: 1089-1094.
23. Bakker WH, Krenning EP, Breeman WA, Koper JW, Kooij PP, Reubi JC, Klijn JG, Visser TJ, Docter R, Lamberts SW. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals. J Nucl Med 1990; 31: 1501-1509.
24. Hammond PJ, Wade AF, Gwilliam ME, Peters AM, Myers MJ, Gilbey SG, Bloom SR, Calam J. Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue. Br J Cancer 1993; 67: 1437-1439.
25. Anderson CJ, Sherman ELC, McCarthy DW, Bass LA, Jones LA, Cristle ME, Lahahn MV, Shefer RE, Klinkostein RE, Welch MJ. Radiotherapy studies of Cu-64-labeled TETA-octreotide in tumor-bearing rats. J Nucl Med 1996; 37(5 Suppl): 128P.
26. Reubi JC, Kvols L. Somatostatin receptors in human renal cell carcinomas. Cancer Res 1992; 52: 6074-6078.
27. Taylor JE, Theveniau MA, Bahirzadeh R, Reisine T, Eden PA. Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity. Peptides 1994; 15: 1229-1236.
28. Madiyalakan R, Sykes TR, Dharampaul S, Sykes CJ, Baum RP, Hor G, Noujaim AA. Antiidiotype induction therapy: evidence for the induction of immune response through the idiotype network in patients with ovarian cancer after administration of anti-CA125 murine monoclonal antibody B43.13. Hybridoma 1995; 14: 199-203.
29. Otte A, Jermann E, Behe M, Goetze M, Bucher HC, Roser HW, Heppeler A, Mueller-Brand J, Maecke HR. DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy. Eur J Nucl Med 1997; 24: 792-795.